Dada Nexus Stock (NASDAQ:DADA), Trade Ideas

Dada Nexus

Dada Nexus is a leading crowdsourced delivery service in China. The company has two core businesses, Dada Now, which is an on-demand delivery platform that provides last-mile and intracity services; and JD Daojia, or JDDJ, which is an online on-demand retail platform that connects consumers to merchants with its delivery capabilities. As of 2022, Dada Now accounted for 34% of revenue while JDDJ accounted for the rest. JDDJ and Dada Nexus merged in 2016, where JD.com received 47.4% ownership of the merged entity in exchange for its JDDJ business. As of June 2023, JD.com and Walmart Inc own 53.9% and 9.3% of Dada Nexus, respectively. Dada Nexus competes with other logistics companies such as SF Intra-City, with Didi in its delivery business, and with Meituan in its on-demand retail segment.

News

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

AKBA

APCX

BCAN

CDLX

CEIX

CHEK

CISS

DADA

DERM

DNUT

EGOX

ETAO

GLUE

GOEV

GWAV

IPDN

IVVD

MESO

MRNO

NBSE

NGVC

NOVA

NUVB

OPGN

PRAX

QRTEB

RDDT

STOK

SXTP

TIVC

TSLA

VKTX

WPRT

Shares of  Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected fourth-quarter loss.

Westport Fuel Systems posted a quarter loss of 81 cents per share, compared to market expectations for a loss of 51 cents per share.

Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday&#39;s Mid-Day Session

Pre-Market Outlook

BREA

BZFD

INTJ

VIVK

Shares of  Stoke Therapeutics, Inc. (NASDAQ: STOK) rose sharply in today’s pre-market trading after the company announced Phase 1/2a data supporting the potential for STK-001 

Why Stoke Therapeutics Shares Are Trading Higher By Around 70%; Here Are 20 Stocks Moving Premarket

FINV

MNSO

SBLK

TLRY

U.S. stock futures were higher this morning, with the Nasdaq futures gaining by around 70 points on Tuesday.

Shares of  Dada Nexus Limited  (NASDAQ: DADA) shares fell sharply in today&#39;s pre-market trading after the company reported downbeat fourth-quarter results.

Dada Nexus Posts Downbeat Results, Joins GDS Holdings And Other Big Stocks Moving Lower In Tuesday&#39;s Pre-Market Session

Dada Nexus Limited - American Depositary Shares

Dada Nexus Ltd

In the last three months, 4 analysts have published ratings on Dada Nexus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DADA#NASDAQ">DADA</a>), offering a diverse range of perspectives from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $2.62, a high estimate of $3.50, and a low estimate of $2.00. This current average represents a 69.53% decrease from the previous average price target of $8.60. 
<img src="https://www.benzinga.com/files/images/story/2024/1714068082_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
The perception of Dada Nexus by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ronald Keung</td>
<td>Goldman Sachs</td>
<td>Announces</td>
<td>Neutral</td>
<td>$2.10</td>
<td>-</td>
</tr>
<tr>
<td>Thomas Chong</td>
<td>Jefferies</td>
<td>Lowers</td>
<td>Buy</td>
<td>$2.90</td>
<td>$8.60</td>
</tr>
<tr>
<td>Jin Yoon</td>
<td>New Street Research</td>
<td>Announces</td>
<td>Neutral</td>
<td>$2.00</td>
<td>-</td>
</tr>
<tr>
<td>Robin Leung</td>
<td>Daiwa Capital</td>
<td>Announces</td>
<td>Buy</td>
<td>$3.50</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Dada Nexus. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Dada Nexus compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Dada Nexus's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
To gain a panoramic view of Dada Nexus's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/DADA/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Dada Nexus analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>About Dada Nexus</h2>
Dada Nexus is a leading crowdsourced delivery service in China. The company has two core businesses, Dada Now, which is an on-demand delivery platform that provides last-mile and intracity services; and JD Daojia, or JDDJ, which is an online on-demand retail platform that connects consumers to merchants with its delivery capabilities. As of 2022, Dada Now accounted for 34% of revenue while JDDJ accounted for the rest. JDDJ and Dada Nexus merged in 2016, where JD.com received 47.4% ownership of the merged entity in exchange for its JDDJ business. As of June 2023, JD.com and Walmart Inc own 53.9% and 9.3% of Dada Nexus, respectively. Dada Nexus competes with other logistics companies such as SF Intra-City, with Didi in its delivery business, and with Meituan in its on-demand retail segment.
<h3>Financial Insights: Dada Nexus</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Challenges: Dada Nexus's revenue growth over 3 months faced difficulties. As of 31 December, 2023, the company experienced a decline of approximately -15.94%. This indicates a decrease in top-line earnings. When compared to others in the Consumer Staples sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Dada Nexus's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of -56.9%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Dada Nexus's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of -20.71%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Dada Nexus's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -15.75%, the company may face hurdles in achieving optimal financial returns.
Debt Management: With a below-average debt-to-equity ratio of 0.0, Dada Nexus adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>Analyst Ratings: What Are They?</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

Unveiling 4 Analyst Insights On Dada Nexus

Goldman Sachs analyst Ronald Keung reinstates Dada Nexus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DADA#NASDAQ">DADA</a>) with a Neutral and announces $2.1 price target.

Price Target

Initiation

Goldman Sachs Reinstates Neutral on Dada Nexus, Announces $2.1 Price Target

Shares of Westport Fuel Systems Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wprt#NASDAQ">WPRT</a>) fell sharply during Tuesday&rsquo;s session after posting a wider-than-expected fourth-quarter loss.
Westport Fuel Systems posted a quarter loss of 81 cents per share, compared to market expectations for a loss of 51 cents per share.
Westport Fuel Systems shares dipped 9.9% to $6.52 on Monday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Stoke Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/stok#NASDAQ">STOK</a>) shares gained 72.6% to $11.24 after the company announced Phase 1/2a data supporting the potential for STK-001 in Dravet syndrome.</li>
<li>C3is Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ciss#NASDAQ">CISS</a>) climbed 65% to $0.0581 after the company reported a year-over-year increase in fourth-quarter financial results.</li>
<li>OpGen, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/opgn#NASDAQ">OPGN</a>) shares climbed 48.2% to $0.7039 after the company entered into a securities purchase agreement with a private investor, David Lazar, to acquire 3 million shares of Series E Convertible Preferred Stock at $1.00 per share for aggregate gross proceeds of $3.0 million.</li>
<li>Mesoblast Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/meso#NASDAQ">MESO</a>) gained 43.2% to $3.1501. Mesoblast was notified by the U.S. FDA that available clinical data from Phase 3 trial appear sufficient to support BLA submission for Remestemcel-L in children with steroid-refractory acute graft versus host disease.</li>
<li>Praxis Precision Medicines Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prax#NASDAQ">PRAX</a>) gained 31.9% to $66.63 after the company reported results from a Phase 2a proof of concept study evaluating PRAX-628 in epilepsy patients with PPR.</li>
<li>Nuvation Bio Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nuvb#NYSE">NUVB</a>) climbed 24.4% to $2.80 after BTIG upgraded the stock from Neutral to Buy.</li>
<li>Check-Cap Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/chek#NASDAQ">CHEK</a>) shares gained 24.3% to $2.40 after the company announced that it entered into a definitive Business Combination Agreement with Nobul AI.</li>
<li>Viking Therapeutics Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vktx#NASDAQ">VKTX</a>) shares climbed 23.3% to $85.29 after the company announced results from its Phase 1 multiple ascending dose clinical trial of an oral tablet formulation of VK2735.</li>
<li>Krispy Kreme, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dnut#NASDAQ">DNUT</a>) gained 21.3% to $15.10 after the company and McDonald&#39;s expanded their partnership, with Krispy Kreme to provide donuts at McDonald&#39;s locations nationwide.</li>
<li>Journey Medical Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/derm#NASDAQ">DERM</a>) gained 19.9% to $3.50.</li>
<li>Akso Health Group (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ahg#NASDAQ">AHG</a>) climbed 17.5% to $1.21.</li>
<li>9F Inc &ndash; ADR (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jfu#NASDAQ">JFU</a>) gained 17% to $3.50.</li>
<li>Invivyd, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ivvd#NASDAQ">IVVD</a>) gained 17% to $3.78. Morgan Stanley analyst Maxwell Skor upgraded Invivyd from Equal-Weight to Overweight and raised the price target from $4 to $10.</li>
<li>Sunnova Energy International Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nova#NYSE">NOVA</a>) shares gained 16.4% to $6.28 after the company announced that it will be the sole provider of solar and battery storage services in The Home Depot stores across the United States and its territories.</li>
<li>Greenwave Technology Solutions, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gwav#NASDAQ">GWAV</a>) climbed 16.3% to $0.18 after surging 24% on Monday. Greenwave Technology Solutions 13G filing showed Joseph Reda reported a 9.119% stake in the co as of March 22, 2024.</li>
<li>Reddit Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rddt#NYSE">RDDT</a>) climbed 15.8% to $69.26 amid post-IPO volatility.</li>
<li>Canopy Growth Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cgc#NASDAQ">CGC</a>) shares gained 15.6% to $7.17.</li>
<li>Qurate Retail Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qrteb#NASDAQ">QRTEB</a>) climbed 13.7% to $4.40.</li>
<li>Natural Grocers by Vitamin Cottage Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ngvc#NYSE">NGVC</a>) climbed 13.4% to $19.25.</li>
<li>60 Degrees Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sxtp#NASDAQ">SXTP</a>) shares rose 9.8% to $0.2660 after dipping 10% on Monday.</li>
<li>Seagate Technology Holdings PLC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/stx#NASDAQ">STX</a>) gained 9.2% to $96.33 after Morgan Stanley upgraded the stock from Equal-Weight to Overweight and raised its price target from $73 to $115.</li>
<li>McCormick &amp; Company Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mkc#NYSE">MKC</a>) climbed 9% to $76.24 after the company reported better-than-expected first-quarter financial results.</li>
<li>IHS Holding Ltd (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ihs#NYSE">IHS</a>) climbed 7.6% to $3.74.</li>
<li>Tesla Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tsla#NASDAQ">TSLA</a>) gained 5.8% to $182.65 amid reports suggest Italy has approached the company about electric truck production.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Quhuo Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qh#NASDAQ">QH</a>) dipped 68.5% to $0.40.</li>
<li>NeuBase Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nbse#NASDAQ">NBSE</a>) fell 51.8% to $0.48 after declining around 3% on Monday.</li>
<li>Cardlytics Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cdlx#NASDAQ">CDLX</a>) dipped 40.4% to $12.06 after the company announced a $150 million proposed convertible senior notes offering.</li>
<li>AppTech Payments Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/apcx#NASDAQ">APCX</a>) fell 39.3% to $1.00 after the company priced its 2 million share offering at $1 per share.</li>
<li>Next.e.GO N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/egox#NASDAQ">EGOX</a>) shares tumbled 27.6% to $0.037 after jumping around 30% on Monday.</li>
<li>Professional Diversity Network Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ipdn#NASDAQ">IPDN</a>) fell 27.2% to $1.82.</li>
<li>Canoo Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/goev#NASDAQ">GOEV</a>) shares fell 21.4% to $3.30.</li>
<li>GDS Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gds#NASDAQ">GDS</a>) fell 20.2% to $6.68 after the company reported fourth-quarter results, disclosed equity raise and new CEO for its international business.</li>
<li>Equillium Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eq#NASDAQ">EQ</a>) shares declined 20.1% to $1.95 following fourth-quarter results.</li>
<li>BYND Cannasoft Enterprises (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bcan#NASDAQ">BCAN</a>) shares fell 17.9% to $1.61.</li>
<li>Murano Global Investments Plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrno#NASDAQ">MRNO</a>) shares declined 17.9% to $14.78.</li>
<li>Dada Nexus Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dada#NASDAQ">DADA</a>) shares dropped 17.8% to $2.08 after the company reported downbeat fourth-quarter results.</li>
<li>Etao International (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/etao#NASDAQ">ETAO</a>) shares fell 14.7% to $4.35.</li>
<li>Tivic Health Systems, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tivc#NASDAQ">TIVC</a>) fell 14.4% to $1.24 after posting fourth-quarter results.</li>
<li>Akebia Therapeutics Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/akba#NASDAQ">AKBA</a>) shares dipped 9.5% to $2.00.</li>
<li>Graphjet Technology (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gti#NASDAQ">GTI</a>) fell 9.3% to $7.26.</li>
<li>Monte Rosa Therapeutics Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/glue#NASDAQ">GLUE</a>) dipped 8.4% to $7.75.</li>
<li>Consol Energy Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ceix#NYSE">CEIX</a>) declined 8.1% to $79.36.</li>
<li>RH (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rh#NYSE">RH</a>) fell 4% to $276.00. Telsey Advisory Group analyst Joseph Feldman reiterated RH with a Market Perform and maintained a $285 price target.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/24/03/37934560/ethereum-surpasses-3-600-dogwifhat-emerges-as-top-gainer"> Ethereum Surpasses $3,600; dogwifhat Emerges As Top Gainer</a>

Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Shares of Stoke Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/stok#NASDAQ">STOK</a>) rose sharply in today&rsquo;s pre-market trading after the company announced Phase 1/2a data supporting the potential for <a href="https://www.benzinga.com/general/biotech/24/03/37923355/stoke-therapeutics-stock-rockets-on-phase-12a-data-heres-why">STK-001 in Dravet syndrome</a>.
Stoke Therapeutics shares jumped 69.7% to $11.03 in pre-market trading
Here are some other stocks moving in pre-market trading.
<h3>Gainers</h3>
<ul>
<li>Check-Cap Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/chek#NASDAQ">CHEK</a>) shares gained 38.3% to $2.67 in pre-market trading. Nobul AI Corp entered into business combination agreement with Check-Cap.</li>
<li>C3is Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ciss#NASDAQ">CISS</a>) rose 35.2% to $0.0476 in pre-market trading. C3is is expected to release its fourth quarter financial results before the opening bell on March 26, 2024.</li>
<li>OpGen, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/opgn#NASDAQ">OPGN</a>) gained 30.4% to $0.6196 in pre-market trading after the company announced David Lazar will invest $3 million in preferred stock and take over as CEO.</li>
<li>Mesoblast Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/meso#NASDAQ">MESO</a>) gained 23.2% to $2.71 in pre-market trading. Mesoblast was notified by the U.S. FDA that available clinical data from Phase 3 trial appear sufficient to support BLA submission for Remestemcel-L in children with steroid-refractory acute graft versus host disease.</li>
<li>Intelligent Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/intj#NASDAQ">INTJ</a>) shares rose 19.7% to $2.31 in pre-market trading after dipping around 9% on Monday.</li>
<li>Krispy Kreme, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dnut#NASDAQ">DNUT</a>) gained 16.3% to $14.48 in pre-market trading. McDonald&#39;s USA and Krispy Kreme announced expanded national partnership.</li>
<li>60 Degrees Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sxtp#NASDAQ">SXTP</a>) shares rose 15.6% to $0.28 in pre-market trading after dipping 10% on Monday.</li>
<li>Invivyd, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ivvd#NASDAQ">IVVD</a>) gained 13% to $3.65 in pre-market trading. Morgan Stanley analyst Maxwell Skor upgraded Invivyd from Equal-Weight to Overweight and raised the price target from $4 to $10.</li>
<li>Greenwave Technology Solutions, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gwav#NASDAQ">GWAV</a>) climbed 10.3% to $0.1661 in pre-market trading after surging 24% on Monday. Greenwave Technology Solutions 13G filing showed Joseph Reda reported a 9.119% stake in the co as of March 22, 2024.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>NeuBase Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nbse#NASDAQ">NBSE</a>) dipped 54.5% to $0.4497 in pre-market trading after declining around 3% on Monday.</li>
<li>AppTech Payments Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/apcx#NASDAQ">APCX</a>) declined 35.8% to $1.06 in pre-market trading as the company disclosed a proposed underwritten public offering of common stock.</li>
<li>Tivic Health Systems, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tivc#NASDAQ">TIVC</a>) fell 20% to $1.16 pre-market trading after posting fourth-quarter results.</li>
<li>BuzzFeed, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bzfd#NASDAQ">BZFD</a>) fell 12.5% to $0.3530 pre-market trading after the company posted downbeat results for its fourth quarter on Monday. The company also said it sees first-quarter overall revenues of $42 million to $44 million.</li>
<li>Vivakor, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vivk#NASDAQ">VIVK</a>) shares fell 12.2% to $0.7285 in pre-market trading. Vivakor shares fell around 7% on Monday after the company announced that it signed a definitive Membership Interest Purchase Agreement to acquire Endeavor Entities.</li>
<li>Next.e.GO N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/egox#NASDAQ">EGOX</a>) shares tumbled 11.6% to $0.0450 in pre-market trading after jumping around 30% on Monday.</li>
<li>Westport Fuel Systems Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wprt#NASDAQ">WPRT</a>) fell 10.5% to $6.47 in pre-market trading after posting a wider-than-expected fourth-quarter loss.</li>
<li>Brera Holdings PLC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/brea#NASDAQ">BREA</a>) fell 10.3% to $1.31 in pre-market trading.</li>
<li>Dada Nexus Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dada#NASDAQ">DADA</a>) shares dropped 9.1% to $2.30 in pre-market trading after the company reported downbeat fourth-quarter results.</li>
<li>GDS Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gds#NASDAQ">GDS</a>) fell 6.1% to $7.86 in pre-market trading&nbsp;following fourth-quarter results.&nbsp;GDS named Jamie Khoo as CEO of GDS International.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/03/37908125/cramer-isnt-knocking-this-pharma-firm-anymore-as-a-matter-of-fact-im-going-in"> Cramer Isn&#39;t &#39;Knocking&#39; This Pharma Firm Anymore: &#39;As A Matter Of Fact, I&#39;m Going In&#39;</a>

WIIM

Dada Nexus shares are trading lower after the company reported worse-than-expected Q4 EPS and revenues.

U.S. stock futures were higher this morning, with the Nasdaq futures gaining by around 70 points on Tuesday.
Shares of Dada Nexus Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dada#NASDAQ">DADA</a>) shares fell sharply in today&#39;s pre-market trading after the company reported downbeat fourth-quarter results.
The company&rsquo;s board authorized share repurchase program of up to $40 million of American Depository Shares for two-year period through March 2026.
Dada Nexus shares dipped 9.1% to $2.30 in pre-market trading.
Here are some big stocks recording losses in today&rsquo;s pre-market trading session.
<ul>
<li>GDS Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gds#NASDAQ">GDS</a>) fell 6.1% to $7.86 in pre-market trading. GDS Holdings is expected to report its fourth quarter and full year 2023 unaudited financial results today.</li>
<li>Star Bulk Carriers Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sblk#NASDAQ">SBLK</a>) shares declined 4.4% to $23.30 in pre-market trading.</li>
<li>FinVolution Group (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/finv#NYSE">FINV</a>) fell 3.9% to $4.74 in pre-market trading. FinVolution, last week, posted downbeat quarterly sales.</li>
<li>M&amp;T Bank Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mtb#NYSE">MTB</a>) declined 3.7% to $137.00 in pre-market trading. M&amp;T Bank is expected to report its first quarter 2024 earnings on Monday, April 15, 2024.</li>
<li>Tilray Brands, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tlry#NASDAQ">TLRY</a>) fell 3.3% to $2.08 in pre-market trading after falling around 7% on Monday. Germany approved the legalization of cannabis for adult use.</li>
<li>MINISO Group Holding Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mnso#NYSE">MNSO</a>) fell 2.6% to $20.12 in pre-market trading. MINISO Group recently reported better-than-expected second-quarter financial results.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/03/37908125/cramer-isnt-knocking-this-pharma-firm-anymore-as-a-matter-of-fact-im-going-in"> Cramer Isn&#39;t &#39;Knocking&#39; This Pharma Firm Anymore: &#39;As A Matter Of Fact, I&#39;m Going In&#39;</a>
Don&rsquo;t forget to check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a>

Dada Nexus Posts Downbeat Results, Joins GDS Holdings And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Dada Nexus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DADA#NASDAQ">DADA</a>) reported quarterly Adj losses of $(0.08) per ADS which missed the analyst consensus estimate of $0.08 by 200 percent. This is a 20 percent increase over losses of $(0.10) per ADS from the same period last year. The company reported quarterly sales of $381.95 million which missed the analyst consensus estimate of $430.44 million by 11.26 percent. This is a 1.35 percent increase over sales of $376.87 million the same period last year.

Earnings

Dada Nexus Q4 Adj Earnings Per ADS $(0.08) Misses $0.08 Estimate, Sales $381.95M Miss $430.44M Estimate

Buybacks

Dada Nexus Says Board Has Authorized Share Repurchase Program Of Up To $40M Of American Depository Shares For Two-Year Period Through March 2026

Dada Nexus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DADA#NASDAQ">DADA</a>) reported quarterly sales of $381.95 million.&nbsp;Total net revenues&nbsp;were RMB2,752.2 million, an increase of&nbsp;2.7%&nbsp;year over year from RMB2,681.0 million in the same period of 2022.

Dada Nexus Reports Q4 Sales Of $381.95M

<h3>Companies Reporting Before The Bell</h3>
&bull; Bitcoin Depot (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTM#NASDAQ">BTM</a>) is expected to report quarterly loss at $0.08 per share on revenue of $161.50 million.
&bull; Syra Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYRA#NASDAQ">SYRA</a>) is likely to report quarterly loss at $0.09 per share on revenue of $2.23 million.
&bull; Theriva Biologics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/TOVX#AMEX">TOVX</a>) is likely to report earnings for its fourth quarter.
&bull; LightInTheBox Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LITB#NYSE">LITB</a>) is projected to report earnings for its fourth quarter.
&bull; D-MARKET Electronic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HEPS#NASDAQ">HEPS</a>) is estimated to report earnings for its fourth quarter.
&bull; Viomi Technology Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIOT#NASDAQ">VIOT</a>) is expected to report earnings for its Fiscal Year 2023.
<h3>Companies Reporting After The Bell</h3>
&bull; GreenTree Hospitality Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GHG#NYSE">GHG</a>) is expected to report earnings for its Fiscal Year 2023.
&bull; Rekor Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REKR#NASDAQ">REKR</a>) is expected to report quarterly loss at $0.10 per share on revenue of $10.72 million.
&bull; TMC Metals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMC#NASDAQ">TMC</a>) is estimated to report earnings for its fourth quarter.
&bull; Dada Nexus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DADA#NASDAQ">DADA</a>) is expected to report quarterly earnings at $0.09 per share on revenue of $432.74 million.
&bull; VolitionRX (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/VNRX#AMEX">VNRX</a>) is expected to report quarterly loss at $0.11 per share on revenue of $450 thousand.
&bull; Tivic Health Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIVC#NASDAQ">TIVC</a>) is expected to report earnings for its fourth quarter.
&bull; Lucid Diagnostics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUCD#NASDAQ">LUCD</a>) is expected to report quarterly loss at $0.26 per share on revenue of $1.05 million.
&bull; BuzzFeed (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BZFD#NASDAQ">BZFD</a>) is projected to report quarterly earnings at $0.00 per share on revenue of $104.60 million.
&bull; Sanara MedTech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMTI#NASDAQ">SMTI</a>) is likely to report quarterly loss at $0.13 per share on revenue of $16.50 million.
&bull; Ampco-Pittsburgh (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AP#NYSE">AP</a>) is expected to report earnings for its fourth quarter.
&bull; Westport Fuel Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WPRT#NASDAQ">WPRT</a>) is likely to report quarterly loss at $0.51 per share on revenue of $86.49 million.
This article was generated by Benzinga&#39;s automated content engine and reviewed by an editor.

HEPS

LITB

LUCD

REKR

SMTI

SYRA

TOVX

VIOT

VNRX

Earnings Scheduled For March 25, 2024

With U.S. stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today are as follows:
Wall Street expects Dada Nexus Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dada#NASDAQ">DADA</a>) to report quarterly earnings at 9 cents per share on revenue of $432.74 million after the closing bell, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. Dada Nexus shares gained 0.9% to $2.33 in after-hours trading.
Salarius Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/slrx#NASDAQ">SLRX</a>) posted a net loss of $0.9 million, or 22 cents per share for the fourth quarter, narrower than the year-ago loss of $6.4 million, or $2.83 per share. Salarius Pharmaceuticals shares jumped 50.6% to $0.9335 in the after-hours trading session.
LightInTheBox Holding Co., Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/litb#NYSE">LITB</a>) is expected to release its unaudited financial results for the fourth quarter before the opening bell on Monday. LightInTheBox shares gained 4.9% to close at $0.7929 on Friday.
Check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a> 
Masimo Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/masi#NASDAQ">MASI</a>) shares rose sharply during Friday&rsquo;s after-hours trading session after the company announced it has authorized management to evaluate a proposed separation of its consumer business. The company also reaffirmed its first-quarter and FY24 guidance. Masimo shares jumped 13.9% to $153.65 in the after-hours trading session.
Analysts expect Westport Fuel Systems Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wprt#NASDAQ">WPRT</a>) to post a quarterly loss at 51 cents per share on revenue of $86.49 million after the closing bell. Westport Fuel shares fell 7.1% to $5.85 in the after-hours trading session.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/03/37889794/vista-gold-and-2-other-stocks-under-2-insiders-are-buying"> Vista Gold And 2 Other Stocks Under $2 Insiders Are Buying </a>
&nbsp;

MASI

SLRX

Dada Nexus, Salarius Pharmaceuticals And 3 Stocks To Watch Heading Into Monday

The CNN Money Fear and Greed index showed a decline in the overall market sentiment, while the index remained in the &quot;Greed&quot; zone on Friday.
The Dow Jones index settled lower on Friday but recorded its best week of the year. All three major indices notched gains last week, with the S&amp;P 500 gaining about 2.3%, and the Dow adding approximately 2% to record its best week since December.
Shares of Lululemon Athletica Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lulu#NASDAQ">LULU</a>) fell around 16% during Friday&rsquo;s session after releasing fourth-quarter results. Nike Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nke#NYSE">NKE</a>) shares fell around 7% on Friday after the company reported results for its third quarter. FedEx Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fdx#NYSE">FDX</a>) shares gained over 7% on Friday after the company reported better-than-expected earnings for its third quarter and authorized a new $5 billion share repurchase program on Thursday.
On the economic data front, the total number of active U.S. oil rigs fell by 1 rig this week, Baker Hughes Inc. reported.
Most sectors on the S&amp;P 500 closed on a negative note, with real estate, financial and consumer discretionary stocks recording the biggest losses on Friday. However, information technology and communication services bucked the overall market trend, closing the session higher.
The Dow Jones closed lower by around 305 points to 39,475.90 on Friday. The S&amp;P 500 fell 0.14% at 5,234.18, while the Nasdaq Composite climbed 0.16% at 16,428.82 during Friday&rsquo;s session.
Investors are awaiting earnings results from Westport Fuel Systems Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wprt#NASDAQ">WPRT</a>), BuzzFeed, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bzfd#NASDAQ">BZFD</a>) and Dada Nexus Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dada#NASDAQ">DADA</a>) today.
At a current reading of 71.8, the index remained in the &quot;Greed&quot; zone on Friday, versus a prior reading of 74.3.
What Is The CNN Business Fear &amp; Greed Index?
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next: <a href="https://www.benzinga.com/news/24/03/37889754/top-5-consumer-stocks-that-may-crash-this-month"> Top 5 Consumer Stocks That May Crash This Month</a>

LULU

Investor Sentiment Falls, But Dow Records Strongest Week Since December

Dada Nexus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DADA#NASDAQ">DADA</a>) is set to give its latest quarterly earnings report on Monday, 2024-03-25. Here's what investors need to know before the announcement.
Analysts estimate that Dada Nexus will report an earnings per share (EPS) of $0.09. 
Dada Nexus bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Here's a look at Dada Nexus's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
<th>Q4 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td></td>
<td>-0.02</td>
<td>-0.07</td>
<td>-0.11</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0</td>
<td>0</td>
<td>-0.10</td>
<td>-0.10</td>
</tr>
<tr>
<td>Price Change %</td>
<td>10.0%</td>
<td>5.0%</td>
<td>15.0%</td>
<td>-8.0%</td>
</tr>
</tbody>
</table>

<h3>Stock Performance</h3>
Shares of Dada Nexus were trading at $2.39 as of March 21. Over the last 52-week period, shares are down 70.23%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release. 
<a href="https://www.benzinga.com/quote/DADA/earnings">To track all earnings releases for Dada Nexus visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Preview: Dada Nexus

Across the recent three months, 4 analysts have shared their insights on Dada Nexus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DADA#NASDAQ">DADA</a>), expressing a variety of opinions spanning from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $3.6, a high estimate of $6.00, and a low estimate of $2.00. A decline of 53.85% from the prior average price target is evident in the current average. 
<img src="https://www.benzinga.com/files/images/story/2024/1710176452_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
A clear picture of Dada Nexus's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Thomas Chong</td>
<td>Jefferies</td>
<td>Lowers</td>
<td>Buy</td>
<td>$2.90</td>
<td>$8.60</td>
</tr>
<tr>
<td>Jin Yoon</td>
<td>New Street Research</td>
<td>Announces</td>
<td>Neutral</td>
<td>$2.00</td>
<td>-</td>
</tr>
<tr>
<td>Robin Leung</td>
<td>Daiwa Capital</td>
<td>Announces</td>
<td>Buy</td>
<td>$3.50</td>
<td>-</td>
</tr>
<tr>
<td>James Lee</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Buy</td>
<td>$6.00</td>
<td>$7.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Dada Nexus. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Dada Nexus compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Dada Nexus's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/DADA/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Dada Nexus analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Delving into Dada Nexus's Background</h2>
Dada Nexus is a leading crowdsourced delivery service in China. The company has two core businesses, Dada Now, which is an on-demand delivery platform that provides last-mile and intracity services; and JD Daojia, or JDDJ, which is an online on-demand retail platform that connects consumers to merchants with its delivery capabilities. As of 2022, Dada Now accounted for 34% of revenue while JDDJ accounted for the rest. JDDJ and Dada Nexus merged in 2016, where JD.com received 47.4% ownership of the merged entity in exchange for its JDDJ business. As of June 2023, JD.com and Walmart Inc own 53.9% and 9.3% of Dada Nexus, respectively. Dada Nexus competes with other logistics companies such as SF Intra-City, with Didi in its delivery business, and with Meituan in its on-demand retail segment.
<h3>Dada Nexus: Delving into Financials</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining Dada Nexus's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 20.44% as of 30 September, 2023, showcasing a substantial increase in top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Consumer Staples sector.
Net Margin: Dada Nexus's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of -5.79%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Dada Nexus's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of -2.41%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Dada Nexus's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of -1.93%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: Dada Nexus's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.0.
<h2>The Significance of Analyst Ratings Explained</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Deep Dive Into Dada Nexus Stock: Analyst Perspectives (4 Ratings)

Jefferies has decided to maintain its Buy rating of Dada Nexus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DADA#NASDAQ">DADA</a>) and lower its price target from $8.60 to $2.90.
Shares of Dada Nexus are trading up 1.3% over the last 24 hours, at $2.34 per share.
A move to $2.90 would account for a 23.93% increase from the current share price.
<h3>About Dada Nexus</h3>
Dada Nexus is a leading crowdsourced delivery service in China. The company has two core businesses, Dada Now, which is an on-demand delivery platform that provides last-mile and intracity services; and JD Daojia, or JDDJ, which is an online on-demand retail platform that connects consumers to merchants with its delivery capabilities. As of 2022, Dada Now accounted for 34% of revenue while JDDJ accounted for the rest. JDDJ and Dada Nexus merged in 2016, where JD.com received 47.4% ownership of the merged entity in exchange for its JDDJ business. As of June 2023, JD.com and Walmart Inc own 53.9% and 9.3% of Dada Nexus, respectively. Dada Nexus competes with other logistics companies such as SF Intra-City, with Didi in its delivery business, and with Meituan in its on-demand retail segment.
<h3>About Analyst Ratings</h3>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along with analyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Jefferies Maintains Buy Rating for Dada Nexus: Here's What You Need To Know

Jefferies analyst Thomas Chong maintains Dada Nexus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DADA#NASDAQ">DADA</a>) with a Buy and lowers the price target from $8.6 to $2.9.

Jefferies Maintains Buy on Dada Nexus, Lowers Price Target to $2.9

BABA

BEKE

BIDU

FUTU

HTHT

HUYA

Citigourp Global Markets 2% Protected Notes Linked To The Djia

Shares of Chinese stocks are trading higher following the annual National People's Congress event. Additionally, China's consumer price index rose, possibly easing some deflation concerns.

U.S. stock futures were mixed this morning, with the Nasdaq futures gaining by around 0.1% points on Thursday.
Shares of Victoria&#39;s Secret &amp; Co. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vsco#NYSE">VSCO</a>) fell sharply in today&rsquo;s pre-market trading after <a href="https://www.benzinga.com/news/earnings/24/03/37522113/victorias-secret-stock-is-spiraling-lower-whats-going-on">reporting fourth-quarter results.</a>
Victoria&rsquo;s Secret posted upbeat earnings for its fourth quarter, while sales missed estimates. The company&rsquo;s board also authorized a new share repurchase program of up to $250 million. The company also guided for full-year 2024 revenue of around $6 billion versus estimates of $6.28 billion, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Victoria&#39;s Secret shares tumbled 32.1% to $17.40 in pre-market trading.
Here are some big stocks recording losses in today&rsquo;s pre-market trading session.
<ul>
<li>Avid Bioservices, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cdmo#NASDAQ">CDMO</a>) shares tumbled 27.4% to $6.38 in pre-market trading after the company reported certain preliminary third-quarter financial results and announced a proposed $160 million private placement of convertible notes.</li>
<li>Solowin Holdings (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/swin#NASDAQ">SWIN</a>) dipped 21.3% to $37.00 in pre-market trading after jumping 135% on Wednesday.</li>
<li>ADT Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/adt#NYSE">ADT</a>) shares fell 12.9% to $6.51 in pre-market trading as the company reported pricing of secondary public offering of common stock and concurrent share repurchase.</li>
<li>TriplePoint Venture Growth BDC Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tpvg#NYSE">TPVG</a>) declined 8% to $10.00 in pre-market trading after the company reported worse-than-expected fourth-quarter financial results.</li>
<li>MMTec, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mtc#NASDAQ">MTC</a>) shares slipped 5.6% to $2.18 in pre-market trading after declining around 4% on Wednesday.</li>
<li>Dada Nexus Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dada#NASDAQ">DADA</a>) shares fell 5.1% to $2.43 in pre-market trading. Dada Nexus filed documents with the SEC late Tuesday following the completion of an independent review.</li>
<li>XPeng Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/xpev#NYSE">XPEV</a>) shares fell 4% to $9.22 in pre-market trading after gaining around 5% on Wednesday.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/03/37527656/investor-sentiment-improves-slightly-us-stocks-record-gains"> Investor Sentiment Improves Slightly, US Stocks Record Gains </a>
Don&rsquo;t forget to check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a>

CDMO

SWIN

TPVG

VSCO

XPEV

Victoria's Secret Posts Weak Sales, Joins ADT, Avid Bioservices And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Shares of United Natural Foods, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/unfi#NYSE">UNFI</a>) fell sharply during Wednesday&rsquo;s session following <a href="https://www.benzinga.com/quote/UNFI/earnings">second-quarter results.</a>
United Natural Foods posted adjusted earnings of 7 cents per share, compared to market estimates for a loss of 1 cent per share. The company&rsquo;s quarterly sales came in at $7.78 billion, versus expectations of $7.87 billion, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
United Natural Foods named Giorgio Matteo Tarditi as President and Chief Financial Officer.
United Natural Foods shares dipped 15.2% to $12.61 on Wednesday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Rail Vision Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rvsn#NASDAQ">RVSN</a>) shares jumped 115.2% to $4.24. Rail Vision announced first commercial installation of its AI-driven main line systems in a national railways line.</li>
<li>Aptorum Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/apm#NASDAQ">APM</a>) shares climbed 90.1% to $3.1750. Aptorum Group announced an agreement and plan of merger with YOOV Group Holding Ltd and a split-off agreement to separate its legacy business.</li>
<li>NKGen Biotech, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nkgn#NASDAQ">NKGN</a>) gained 46.5% to $1.35.</li>
<li>TRxADE HEALTH, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/meds#NASDAQ">MEDS</a>) rose 39.2% to $11.19 after the company announced a special cash dividend of $8 per share.</li>
<li>Airship AI Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aisp#NASDAQ">AISP</a>) shares climbed 37.8% to $6.82. Airship AI Holdings shares jumped 200% on Tuesday after the company announced that it has been awarded a contract with the Department of Justice for its Acropolis Enterprise Sensor Management video and data management platform.</li>
<li>Enviva Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/eva#NYSE">EVA</a>) rose 33% to $0.9854 after gaining 42% on Tuesday.</li>
<li>American Public Education, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/apei#NASDAQ">APEI</a>) gained 31.8% to $14.99 following upbeat quarterly results.</li>
<li>Dada Nexus Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dada#NASDAQ">DADA</a>) climbed 30.6% to $2.5740. Dada Nexus said certain revenues and associated costs were overstated in past financial statements.</li>
<li>Cemtrex, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cetx#NASDAQ">CETX</a>) gained 30% to $4.4361. Cemtrex announced beta release of pioneering AI gun detection feature.</li>
<li>Wave Life Sciences Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wve#NYSE">WVE</a>) gained 28.5% to $6.16 following upbeat quarterly results.</li>
<li>Vincerx Pharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vinc#NASDAQ">VINC</a>) shares gained 24.5% to $6.89. Vincerx will present three posters at the American Association for Cancer Research (AACR) Annual Meeting 2024.</li>
<li>XORTX Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xrtx#NASDAQ">XRTX</a>) rose 24.2% to $5.85.</li>
<li>CareMax, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmax#NASDAQ">CMAX</a>) gained 23.8% to $14.72.</li>
<li>Lantern Pharma Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ltrn#NASDAQ">LTRN</a>) gained 22.6% to $5.90.</li>
<li>Energem Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/encp#NASDAQ">ENCP</a>) rose 22.4% to $8.31. Energem&rsquo;s merger partner recently said it accelerated the timeline for its planned manufacturing plant in Malaysia.</li>
<li>Cerus Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cers#NASDAQ">CERS</a>) gained 22.4% to $2.4350 after the company reported better-than-expected fourth-quarter GAAP EPS results.</li>
<li>Infobird Co., Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ifbd#NASDAQ">IFBD</a>) jumped 22.4% to $6.40.</li>
<li>Genprex, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gnpx#NASDAQ">GNPX</a>) rose 22.1% to $5.03.</li>
<li>BeyondSpring Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bysi#NASDAQ">BYSI</a>) gained 21% to $3.5098.</li>
<li>Crexendo, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cxdo#NASDAQ">CXDO</a>) surged 20% to $6.43 following upbeat quarterly results.</li>
<li>CrowdStrike Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crwd#NASDAQ">CRWD</a>) shares gained 17.2% to $348.73 after the company reported better-than-expected fourth-quarter earnings and revenues and issued upbeat guidance for FY25.</li>
<li>Fulcrum Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fulc#NASDAQ">FULC</a>) rose 17.2% to $12.85.</li>
<li>JD.com, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jd#NASDAQ">JD</a>) gained 17% to $25.08 after the company reported fourth-quarter results above estimates, a new buyback approval and annual cash dividend.</li>
<li>Hippo Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hipo#NASDAQ">HIPO</a>) rose 14.6% to $16.58 after the company reported better-than-expected fourth-quarter financial results.</li>
<li>Root, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/root#NASDAQ">ROOT</a>) rose 13.7% to $44.46.</li>
<li>Super Group (SGHC) Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sghc#NYSE">SGHC</a>) surged 10.1% to $3.4350 following fourth-quarter results.</li>
<li>Infinera Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/infn#NASDAQ">INFN</a>) gained 10% to $5.66. Infinera announced availability of next generation multi-haul optical line system functionality for industry-leading GX series platform.</li>
<li>MicroStrategy Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mstr#NASDAQ">MSTR</a>) gained 10% to $1,156.87. MicroStrategy shares fell over 21% on Tuesday after the company announced a proposed private offering of $600 million of convertible senior notes.</li>
<li>Lyft, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lyft#NASDAQ">LYFT</a>) gained 9.4% to $18.45.</li>
<li>Couchbase, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/base#NASDAQ">BASE</a>) shares rose 9.2% to $29.37 after the company reported upbeat fourth-quarter sales and issued upbeat revenue guidance for the first quarter.</li>
<li>NIO Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nio#NYSE">NIO</a>) gained 5.9% to $5.80. On Tuesday, NIO reported fourth-quarter revenue of 17.10 billion yuan ($2.41 billion), up by 6.5% year-over-year and down by 10.3% from the previous quarter.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Entravision Communications Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/evc#NYSE">EVC</a>) shares fell 51.1% to $1.7450 after the company received communication from Meta indicating its intention to wind down its ASP program globally, ending its relationship with all ASPs, including Entravision, by July 1. The ASP program represented a large portion of Entravision&#39;s total consolidated revenue.</li>
<li>Neptune Wellness Solutions Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nept#NASDAQ">NEPT</a>) fell 46.4% to $0.20. Neptune announced decision of Nasdaq Hearings Panel to delist common shares.</li>
<li>bioAffinity Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/biaf#NASDAQ">BIAF</a>) fell 45% to $1.6499 after the company announced pricing of a $2.5 million registered direct offering and a concurrent private placement.</li>
<li>Ocean Biomedical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ocea#NASDAQ">OCEA</a>) fell 30.5% to $3.6550</li>
<li>Heart Test Laboratories, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hscs#NASDAQ">HSCS</a>) fell 29% to $0.1272. HeartSciences announced Canada patent grant covering MyoVista Wavelet Technology.</li>
<li>Jaguar Health, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jagx#NASDAQ">JAGX</a>) shares fell 26.7% to $0.0924 after dipping around 12% on Tuesday.</li>
<li>Sunshine Biopharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sbfm#NASDAQ">SBFM</a>) dipped 25.8% to $0.0620.</li>
<li>Affimed N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/afmd#NASDAQ">AFMD</a>) fell 22.3% to $0.52 after the company announced a 1-for-10 reverse stock split.</li>
<li>Phunware, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/phun#NASDAQ">PHUN</a>) shares fell 21.8% to $11.49. Phunware shares jumped over 18% on Tuesday amid volatility in Trump-related stocks after Donald Trump won the North Dakota Caucus.</li>
<li>PureCycle Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pct#NASDAQ">PCT</a>) dipped 16.7% to $4.71 as the company announced a corporate update for the fourth quarter and fiscal year ending Dec. 31, 2023.</li>
<li>Nordstrom, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/jwn#NYSE">JWN</a>) declined 14.6% to $17.83 after the company issued soft FY24 EPS guidance.</li>
<li>Momentus Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mnts#NASDAQ">MNTS</a>) shares fell 13.2% to $0.6510. Momentus recently received a flight and payload integration services contract from NASA. In another development, Momentus entered into a securities purchase agreement with a single U.S. institutional investor for the purchase and sale of 4.62 million shares of common stock at a purchase price of $0.865 per share and warrant pursuant to a registered direct offering, resulting in total gross proceeds of approximately $4.0 million.</li>
<li>Grifols, S.A. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grfs#NASDAQ">GRFS</a>) fell 13.1% to $5.36 after declining around 7% on Tuesday.</li>
<li>THOR Industries, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tho#NYSE">THO</a>) dipped 11.4% to $112.19 after the company reported a year-over-year decrease in second-quarter financial results and cut FY24 guidance below estimates.</li>
<li>TTEC Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ttec#NASDAQ">TTEC</a>) fell 10.2% to $11.16 after Canaccord Genuity downgraded the stock from Buy to Hold and lowered its price target from $30 to $13.</li>
<li>Dave Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dave#NASDAQ">DAVE</a>) fell 10% to $32.40. On Tuesday, Dave reported a year-over-year increase in fourth-quarter revenue results.</li>
<li>Brown-Forman Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bf-b#NYSE">BF-B</a>) fell 9.8% to $54.82 after the company reported worse-than-expected third-quarter revenue guidance. Also, the company expects its FY24 organic net sales to be flat.</li>
<li>SOPHiA GENETICS SA (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/soph#NASDAQ">SOPH</a>) shares declined 9.8% to $5.05. Sophia Genetics recently reported worse than expected fourth-quarter earnings and issued 2024 guidance.</li>
<li>Xerox Holdings Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xrx#NASDAQ">XRX</a>) fell 9.6% to $16.99 after the company announced a proposed convertible notes offering.</li>
<li>TAL Education Group (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tal#NYSE">TAL</a>) declined 8.9% to $12.02.</li>
<li>Valley National Bancorp (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vly#NYSE">VLY</a>) dipped 8.5% to $7.20.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/03/37502729/cramer-this-reit-is-a-little-too-dicey-as-for-marathon-digital-own-the-pure"> Cramer: This REIT Is &#39;A Little Too Dicey&#39;; As For Marathon Digital, &#39;Own The Pure&#39;</a>

AFMD

AISP

APEI

BASE

BF-B

BIAF

BYSI

CERS

CETX

CMAX

CRWD

CXDO

DAVE

ENCP

FULC

GNPX

GRFS

HIPO

HSCS

IFBD

INFN

JAGX

LTRN

LYFT

MEDS

MNTS

MSTR

NEPT

NKGN

OCEA

PHUN

ROOT

RVSN

SBFM

SGHC

SOPH

TTEC

UNFI

VINC

XRTX

Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Dada Nexus Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DADA#NASDAQ">DADA</a>) filed documents with the SEC late Tuesday following the completion of an independent review. Here&#8217;s a l<a href="https://www.benzinga.com/news/24/03/37514532/box-reports-upbeat-earnings-joins-american-public-education-wave-life-sciences-and-other-big-stocks">ook at the details</a>.
What To Know:
According to the SEC filings, Mr. Jeff Huijian He, who formerly served as the company's president and director, is stepping down, and Mr. Bing Fu will serve as the interim president.&nbsp;
Also, according to the<a href="https://www.sec.gov/Archives/edgar/data/1793862/000110465924031051/tm247988d2_6k.htm"> documents</a>, Dada Nexus reported certain revenues and associated costs were overstated in past financial statements.&nbsp;
"Specifically, the company's net revenues were overstated by approximately RMB 69 million in the fourth quarter of 2022, RMB 40 million in the first quarter of 2023, RMB 214 million in the second quarter of 2023, and RMB 245 million in the third quarter of 2023, respectively," the company's filing stated.&nbsp;
"The Company's operations and support costs were overstated by approximately RMB70 million in the fourth quarter of 2022, RMB42 million in the first quarter of 2023, RMB214 million in the second quarter of 2023, and RMB250 million in the third quarter of 2023, respectively," according to the filing.&nbsp;
New Street Research analyst Jin Yoon downgraded Dada Nexus from Buy to Neutral and announced a $2 price target on Wednesday.&nbsp;
Related News: <a href="https://www.benzinga.com/news/earnings/24/03/37495066/chargepoint-stock-drops-after-q4-results-heres-why">ChargePoint Stock Drops After Q4 Results &#8211; Here&#8217;s Why</a>
<h2 class="wp-block-heading">DADA Stock Prediction 2024:</h2>
Equity research analysts on and off Wall Street typically use earnings growth and fundamental research as a form of valuation and forecasting. But many in trading turn to technical analysis as a way to form predictive models for share price trajectory.
Some investors look to trends to help forecast where they believe a stock could trade at a certain point in the future. Looking at Dada Nexus, an investor could make an assessment about a stock's long term prospects using a moving average and trend line. If they believe a stock will remain above the moving average, which many believe is a bullish signal, they can extrapolate that trend into the future using a trend line. For Dada Nexus, the 200-day moving average sits at $4.10, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, which is above the current price of $2.56. For more on charts and trend lines, <a href="https://pro.benzinga.com/">see a description here.</a>
Traders believe that when a stock is above its moving average, it is a generally bullish signal, and when it crosses below, it is a more negative signal. Investors could use trend lines to make an educated guess about where a stock could trade at a later date if conditions remain stable.
DADA Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Dada Nexus shares are up 28.7% at $2.53 at the time of publication.
Image: Jacqueline Macou from Pixabay

Dada Nexus Reports Revenue Overstated, President Resigns

GOEV, NBSE and FLGC among pre-market losers

Dada Nexus Ltd ADR (DADA) said after close Monday that it lost $0.08 per share in quarter four 2023. The company reported earnings on an adjusted basis, so it may not be directly comparable to analyst estimates or prior periods.On the revenue line, the company reported $382 million, missing estimates by $48.5 million.In th

Dada Nexus Ltd ADR Down 15.76% To $2.13 After Earnings Miss

Dada Nexus Limited (DADA) Q4 2023 Earnings Call Transcript

REAL and PNST among Consumer Discretionary movers

These Consumer Cyclical stocks are trading higher:-Cazoo Group Ltd (CZOO) stock is trading at $5.73, a gain of $2.08, or 47.42%, on high volume.  Cazoo Group Ltd gets a Sentiment Score of Neutral from InvestorsObserver and receives an average analyst recommendation of Buy with a price target of $274.00. Cazoo Group Ltd nex

Consumer Cyclical Stocks Moving Up and Down Tuesday: CZOO, GRWG, SNBR, RRGB, DADA, GOEV, AUVI, WPRT

Dada Nexus: Justifiably Cheap

Dada Nexus Ltd - ADR (DADA) is up 1.90% today. DADA has an Overall Score of 39. Find out what this means to you and get the rest of the rankings on DADA!See Full DADA ReportDADA stock closed at $2.10 and is up $0.04 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most in

Dada Nexus Ltd - ADR (DADA) has gained 1.90% Thursday In Premarket Trading

The market has been down on Dada Nexus Ltd - ADR (DADA)  stock recently. DADA gets a Bearish score from InvestorsObserver Stock Sentiment Indicator. Dada Nexus Ltd - ADR has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on DADA!See Full DADA ReportWhat is Stock Sentiment?Whe

Should You Buy Dada Nexus Ltd - ADR (DADA) Stock After it Is Lower By 7.79% in a Week?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
If you&rsquo;re an investor with a high tolerance for risk and a desire for supersized returns, <a href="https://investorplace.com/stock-types/penny-stocks/">penny stocks</a> should be at the top of your watchlist. While penny stocks are often associated with pump-and-dump schemes and companies on the verge of bankruptcy, there are some real hidden gems trading at bargain valuations that could potentially deliver astronomical returns within a few short years.



It&rsquo;s not unrealistic to expect a quality penny stock to increase 10X or more within just a couple of years once Wall Street takes notice. Of course, with greater potential reward comes greater risk. Many penny stocks are more speculative in nature. But by focusing your research on profitable companies with solid fundamentals and growth drivers, you can limit the downside while keeping the upside wide open.



In my experience, if you invest wisely in a diversified basket of penny stocks, a $10,000 portfolio can realistically turn into $100,000 or more over a 5-year time. While penny stocks should only be a small part of a well-diversified portfolio, buying up shares of these hidden gems now could pay off in a very big way down the road. So let&rsquo;s dive in and take a closer look at seven penny stocks!



<h2>Paysign (PAYS)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/03/penny-stocks-300x169.png" alt="Stacks of pennies representing penny stocks. Nano-Cap Penny Stocks"><div>Source: John Brueske / Shutterstock.com</div></div>Paysign (NASDAQ:<a href="https://investorplace.com/stock-quotes/pays-stock-quote/">PAYS</a>) provides prepaid card products and processing services for businesses, consumers, and government entities under the PaySign brand. Their capabilities include transaction processing, cardholder enrollment, account funding, account management, reporting, and customer service.



One area I&rsquo;m particularly excited about is how Paysign develops tailored prepaid card programs for corporate incentives, payroll, and gift cards. This provides diversified revenue streams across attractive end markets. The stock has certainly been beaten down, plunging from a 2019 peak of $17.5 to a low of just $1.4 in 2020 as the pandemic took its toll. However, I believe the worst is behind us and that PAYS has bottomed out.



Shares currently trade around $4.10, which I see as an attractive entry point. In my experience, the market tends to underestimate turnaround situations like this. While <a href="https://seekingalpha.com/symbol/PAYS/earnings/estimates">EPS is expected to dip in 2024</a>, analysts forecast a strong 50% rebound in 2025 as growth accelerates again. Revenue growth has remained resilient even through the downturn, with 18% growth expected in 2024 and 14% in 2025.



What gives me further confidence is that Paysign just reported blowout Q4 results, beating estimates by 10.7% on the top line. To me, this quarter confirms we&rsquo;ve reached an inflection point and that Paysign is ready to build momentum as macro conditions improve for fintechs. Once rate cuts materialize, I expect this leaner and refocused PAYS to really take off.



<h2>LiveOne (LVO)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/05/bank-lending-capital-1600-300x169.jpg" alt="hands at desk near laptop computer, with one hand holding a pile of hundred dollar bills. Bank stocks"><div>Source: shutterstock.com/CC7</div></div>LiveOne (NASDAQ:<a href="https://investorplace.com/stock-quotes/lvo-stock-quote/">LVO</a>) presents an intriguing turnaround opportunity as demand normalizes post-pandemic. LiveOne operates a global platform for livestream concerts, festivals, and other events. As you&rsquo;d expect, the stock chart looks ugly if you zoom out. With live events essentially banned for long stretches, LVO shares plunged from its pre-pandemic peaks.



However, the business has been making an impressive comeback in recent quarters. The stock is already up 50% over the past year to around $1.8 currently. And I believe LiveOne can climb much higher from here as financial performance continues improving. Losses have <a href="https://www.google.com/finance/quote/LVO:NASDAQ">narrowed from $44 million in 2022 to $10 million in 2023</a>. Analysts now forecast LiveOne to reach profitability in 2026, with <a href="https://seekingalpha.com/symbol/LVO/earnings/estimates">revenue growth above 20% annually</a> during this period.



Once LiveOne can consistently expand margins after achieving profitability, I think the upside is dramatic given its leadership position in live streaming. This is a small-cap stock with the potential to deliver 10X returns or more in the coming years as the live events industry gets back on track. I believe Wall Street is seriously underestimating LiveOne&rsquo;s potential.



<h2>Dada Nexus (DADA)</h2>



<div><img width="300" height="200" src="https://investorplace.com/wp-content/uploads/2018/08/best-penny-stocks-300x200.jpg" alt="a jar filled with pennies on a table covered in pennies to represent penny stocks"><div>Source: Shutterstock</div></div>Dada Nexus (NASDAQ:<a href="https://investorplace.com/stock-quotes/dada-stock-quote/">DADA</a>) is a leading Chinese local on-demand delivery and retail platform. Dada operates two key platforms &ndash; JD-Daojia, one of China&rsquo;s largest local on-demand retail platforms, and Dada Now, a top local on-demand delivery platform. Dada Now provides critical delivery infrastructure for retailers across industries, serving both merchants and individual customers.



Like the other two picks, DADA&rsquo;s chart is ugly, with shares down 96% from their 2021 peak to around $2 currently. However, I see this as a huge overreaction that has created a buying opportunity. Analysts expect significant improvements as China&rsquo;s economy recovers from COVID disruptions.



Dada has consistently been unprofitable, posting net losses above 20% for years. However, analysts finally forecast the company to reach profitability in 2024 after aggressive cost-cutting. If Dada hits <a href="http://seekingalpha.com/symbol/DADA/earnings/estimates">2025 earnings targets</a>, it would trade at just 5x forward earnings, an absurdly cheap level for a high-growth platform leader.



Given the dramatic improvements on the horizon, I believe DADA can deliver multibagger returns from today&rsquo;s depressed levels. The market has become overly pessimistic on Chinese stocks, presenting a chance to buy Dada at a bargain valuation before the next growth cycle.



<h2>iSun (ISUN)</h2>



<div><img width="300" height="199" src="https://investorplace.com/wp-content/uploads/2014/06/solar-stocks-panel-green-energy-630-ISP-300x199.jpg" alt=""><div>Source: &copy;iStock.com/danielschoenen </div></div>iSun (NASDAQ:<a href="https://investorplace.com/stock-quotes/isun-stock-quote/">ISUN</a>) designs, develops, and installs solar power systems, EV charging stations, and electrical infrastructure solutions. There&rsquo;s no doubt this is one of the riskier penny stocks I&rsquo;ve recommended, with substantial dilution over the past year.



<a href="https://www.macrotrends.net/stocks/charts/ISUN/isun/shares-outstanding">Outstanding shares skyrocketed 121% year-over-year in Q3 2023 alone</a>. I typically avoid profiling stocks with such unfriendly dilution. However, I&rsquo;m making an exception because iSun appears to be approaching an inflection point. Losses narrowed significantly to just $2.3 million in Q3 2023, compared to $28 million in revenue.



This improving trajectory gives me hope the worst dilution is behind us. Shares are also up 83% since its November 2023 trough, potentially indicating dilution has slowed. Analysts forecast negligible losses in 2024, with <a href="https://seekingalpha.com/symbol/ISUN/earnings/estimates">profitability arriving in 2025</a>. If achieved, iSun would trade at a mere 2x 2026 earnings, presenting sizable upside from today&rsquo;s levels. While I recommend watching dilution carefully, I believe iSun could deliver outsized returns if execution continues improving.



<h2>Lesaka Technologies (LSAK)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/stocks-to-buy-2-300x169.jpg" alt="BUY spelled out on a computer keyboard representing stocks to buy"><div>Source: Shutterstock</div></div>Lesaka Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/lsak-stock-quote/">LSAK</a>) is a South African fintech that I believe is poised for a major breakout as conditions improve in its home country. It provides payment solutions and transaction processing services across Africa. The stock has essentially gone sideways for five years now, trading around $4 currently.



However, South Africa&rsquo;s outlook is brightening. Progress is being made on challenges like electricity shortages, high crime, and economic stagnation. With an inflection point potentially approaching, I think LSAK could rally strongly if it can break above resistance around $6.



Losses are forecast to narrow significantly in the years ahead, with <a href="http://seekingalpha.com/symbol/LSAK/earnings/estimates">profitability arriving in 2026</a>. Any positive surprise could ignite the share price. LSAK has the potential for multibagger returns from today&rsquo;s levels if execution remains solid and South Africa&rsquo;s economy turns a corner. This is a classic turnaround play trading at a discount valuation.



<h2>374Water (SCWO)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/stocks-to-buy-3-300x169.jpg" alt='Stocks to buy: A close-up shot of a hand pressing a "BUY NOW!" button on a laptop keyboard.'><div>Source: Shutterstock</div></div>374Water (NASDAQ:<a href="https://investorplace.com/stock-quotes/scwo-stock-quote/">SCWO</a>) is an intriguing nano-cap play on the future of water treatment and sustainability. This social impact clean-tech company provides wastewater treatment solutions using its patented SCWO technology. SCWO eliminates organic compounds, pathogens, and other contaminants.



I expect tailwinds from tightening environmental regulations worldwide. 374Water is still in hypergrowth mode, so profits aren&rsquo;t on the horizon yet. However, revenue is forecast to surge from <a href="https://seekingalpha.com/symbol/SCWO/earnings/estimates">$6 million in 2024 to $55 million in 2026</a>.



Maintaining that triple-digit growth pace could allow 374Water to reach profitability by 2027. Given the huge addressable market in water management, I believe SCWO has multibagger potential if execution remains best-in-class over the next five years. This is an ideal long-term growth story in the making.



<h2>Youdao (DAO)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/02/dao-1600-300x169.png" alt='A concept image of a glowing blue piggy bank with money flowing into it with "DAO" written on it. A network of glowing points of light can be seen in the background.'><div>Source: lp-studio / Shutterstock.com</div></div>Youdao (NYSE:<a href="https://investorplace.com/stock-quotes/dao-stock-quote/">DAO</a>) is a Chinese online education technology company that I believe remains deeply undervalued after the tech selloff. Youdao provides online learning services, smart devices, and digital marketing solutions. As with many Chinese tech names, the stock has been crushed, down 91% from highs.



However, I think a bottom is forming. DAO has traded sideways since August 2023 as fundamentals improved. China&rsquo;s economy is also starting to stabilize. With stimulus ahead, I expect an inflection point for beaten-down <a href="https://investorplace.com/industries/technology/">tech stocks</a> like Youdao.



The company has cut costs aggressively and is <a href="https://seekingalpha.com/symbol/DAO/earnings/estimates">forecast to reach profitability in 2025</a>. At just 5.5x 2026 earnings estimates, I believe the risk/reward is compelling for long-term investors. Revenue growth should also accelerate to 15% annually. My one caution is the high debt load, with a cash/debt ratio of just 0.34x. However, balance sheet improvement should follow with profitability.



On the date of publication, Omor Ibne Ehsan did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines.</a>
<div>Omor Ibne Ehsan is a writer at InvestorPlace. He is a self-taught investor with a focus on growth and cyclical stocks that have strong fundamentals, value, and long-term potential. He also has an interest in high-risk, high-reward investments such as cryptocurrencies and penny stocks. You can follow him on <a href="https://www.linkedin.com/in/omor-ibne-ehsan-56068022b/">LinkedIn</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
The post <a href="https://investorplace.com/2024/04/7-penny-stocks-that-can-turn-10000-into-100000-by-2027/">7 Penny Stocks That Can Turn $10,000 Into $100,000 by 2027</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

7 Penny Stocks That Can Turn $10,000 Into $100,000 by 2027

Dada Nexus Ltd. (DADA) has disclosed a new risk, in the Litigation & Legal Liabilities category. Dada Nexus Ltd. faces a significant business risk ...

Dada Nexus Ltd. Under Siege: Shareholder Lawsuit Threatens Financial Health and Operations